Aluminum-induced osteomalacia: an explanation.
D000535:Aluminum / Q000009:adverse effects* / Q000494:pharmacology; D002113:Calcification, Physiologic / Q000187:drug effects; D002130:Calcium Phosphates / Q000378:metabolism; D002951:Citrates / Q000494:pharmacology; D019343:Citric Acid; D004347:Drug Interactions; D006801:Humans; D010018:Osteomalacia / Q000139:chemically induced*; D006435:Renal Dialysis / Q000009:adverse effects*; D013997:Time Factors; D014511:Uremia / Q000628:therapy*
D002130:Calcium Phosphates; D002951:Citrates; C485828:alpha-tricalcium phosphate; C485830:tetracalcium phosphate; D019343:Citric Acid; C485838:calcium phosphate, monobasic, anhydrous; C020243:calcium phosphate; D000535:Aluminum; C485829:calcium phosphate, dibasic, anhydrous